Mirtazapine Abz

Mirtazapine, the active ingredient in Mirtazapine Abz, is a NaSSA (noradrenergic and specific serotonergic antidepressant) presented as a tablet for oral use. It is prescribed for the management of major depressive disorder in adult patients, improving mood and sleep disturbances associated with the condition.

GNH USA supplies Mirtazapine Abz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with distribution channels that meet EU regulatory standards and ensuring product integrity throughout the supply chain for both acute and maintenance therapy.

Mirtazapine is a noradrenergic and specific serotonergic antidepressant used in the treatment of depressive disorders.

- Major depressive disorder: reduces depressive symptoms and improves overall mood. - Depression with insomnia: promotes sleep onset and continuity while treating depressive symptoms. - Depression with anxiety: alleviates anxiety symptoms alongside mood improvement.

Mirtazapine may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Sedation or drowsiness - Increased appetite and weight gain - Dry mouth - Constipation - Dizziness - Headache

Serious or Rare Side Effects: - Agranulocytosis or severe neutropenia - Life‑threatening allergic reactions (anaphylaxis) - Serotonin syndrome, especially when combined with other serotonergic agents - Significant mood worsening or emergence of suicidal thoughts

Before initiating therapy, clinicians should consider several safety aspects.

- Monitor for worsening depression or emergence of suicidal ideation. - Use cautiously in patients with cardiovascular disease or uncontrolled hypertension. - Avoid abrupt discontinuation to reduce the risk of withdrawal symptoms. - Consider dose adjustment and close monitoring in elderly patients. - Avoid concomitant use with monoamine oxidase inhibitors (MAOIs). - Store at room temperature: keep in the original container, protect from moisture and light.

Mirtazapine can interact with several drug classes, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid): - MAO inhibitors: risk of hypertensive crisis and serotonin syndrome. - Other serotonergic antidepressants (SSRIs, SNRIs, TCAs): increased risk of serotonin syndrome. - CNS depressants (alcohol, benzodiazepines): additive sedation and possible respiratory depression.

Moderate Interactions (Monitor Closely): - CYP2D6 inhibitors (e.g., fluoxetine, paroxetine): may raise mirtazapine plasma concentrations. - Antihistamines (e.g., diphenhydramine): may enhance sedative effects.